209 related articles for article (PubMed ID: 24457557)
1. Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.
Hagen S; Baumann T; Wagner HJ; Morath V; Kaufmann B; Fischer A; Bergmann S; Schindler P; Arndt KM; Müller KM
Sci Rep; 2014 Jan; 4():3759. PubMed ID: 24457557
[TBL] [Abstract][Full Text] [Related]
2. Persistent anti-tumor effects via recombinant adeno-associated virus encoding herpes thymidine kinase gene monitored by PET-imaging.
Kim JY; Kim JH; Khim M; Lee HS; Jung JH; Moon DH; Jeong S; Lee H
Oncol Rep; 2011 May; 25(5):1263-9. PubMed ID: 21331450
[TBL] [Abstract][Full Text] [Related]
3. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
4. Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models.
Carruthers KH; Metzger G; During MJ; Muravlev A; Wang C; Kocak E
Cancer Gene Ther; 2014 Oct; 21(10):434-40. PubMed ID: 25236494
[TBL] [Abstract][Full Text] [Related]
5. Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors.
Kofler DM; Büning H; Mayr C; Bund D; Baumert J; Hallek M; Wendtner CM
Gene Ther; 2004 Sep; 11(18):1416-24. PubMed ID: 15269708
[TBL] [Abstract][Full Text] [Related]
6. Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy.
Puhlmann M; Gnant M; Brown CK; Alexander HR; Bartlett DL
Hum Gene Ther; 1999 Mar; 10(4):649-57. PubMed ID: 10094208
[TBL] [Abstract][Full Text] [Related]
7. Combined antitumor gene therapy with herpes simplex virus-thymidine kinase and short hairpin RNA specific for mammalian target of rapamycin.
Woo HN; Lee WI; Kim JH; Ahn J; Han JH; Lim SY; Lee WW; Lee H
Int J Oncol; 2015 Dec; 47(6):2233-9. PubMed ID: 26459571
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated prodrug-enzyme therapy for CEA-producing colorectal cancer cells.
Okabe S; Arai T; Yamashita H; Sugihara K
J Cancer Res Clin Oncol; 2003 Jun; 129(6):367-73. PubMed ID: 12783317
[TBL] [Abstract][Full Text] [Related]
9. Potent antitumour activity of the combination of HSV-TK and endostatin armed oncolytic adeno-associated virus for bladder cancer in vitro and in vivo.
Pan JG; Zhou X; Zeng GW; Han RF
J Surg Oncol; 2012 Mar; 105(3):249-57. PubMed ID: 21953122
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in gene-directed enzyme prodrug therapy (GDEPT) for cancer.
Niculescu-Duvaz I; Cooper RG; Stribbling SM; Heyes JA; Metcalfe JA; Springer CJ
Curr Opin Mol Ther; 1999 Aug; 1(4):480-6. PubMed ID: 11713763
[TBL] [Abstract][Full Text] [Related]
11. Tissue and cell-type-specific transduction using rAAV vectors in lung diseases.
Kochergin-Nikitsky K; Belova L; Lavrov A; Smirnikhina S
J Mol Med (Berl); 2021 Aug; 99(8):1057-1071. PubMed ID: 34021360
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus and adeno-associated virus vectors.
Lai CM; Lai YK; Rakoczy PE
DNA Cell Biol; 2002 Dec; 21(12):895-913. PubMed ID: 12573049
[TBL] [Abstract][Full Text] [Related]
13. Bound Protein- and Peptide-Based Strategies for Adeno-Associated Virus Vector-Mediated Gene Therapy: Where Do We Stand Now?
Zhang X; Chai Z; Samulski RJ; Li C
Hum Gene Ther; 2020 Nov; 31(21-22):1146-1154. PubMed ID: 32940063
[TBL] [Abstract][Full Text] [Related]
14. Advances in imaging gene-directed enzyme prodrug therapy.
Bhaumik S
Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
[TBL] [Abstract][Full Text] [Related]
15. Origins of Suicide Gene Therapy.
Düzgüneş N
Methods Mol Biol; 2019; 1895():1-9. PubMed ID: 30539525
[TBL] [Abstract][Full Text] [Related]
16. Prodrug cancer gene therapy.
Altaner C
Cancer Lett; 2008 Nov; 270(2):191-201. PubMed ID: 18502571
[TBL] [Abstract][Full Text] [Related]
17. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
18. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
19. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
Muzyczka N; Warrington KH
Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy: recombinant adeno-associated virus vectors.
Smith-Arica JR; Bartlett JS
Curr Cardiol Rep; 2001 Jan; 3(1):43-9. PubMed ID: 11139798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
